Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEAD-010: Dexamethasone Implant for Diabetic Macular Edema
NCT00168389Phase 3Completed
- Sponsor
- Allergan
- Start
- Feb 2005
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in diabetic macular edema (DME) (3 arms), sponsored by Allergan. Primary endpoint: Percentage of Patients With a Best Corrected Visual Acuity (BCVA) Improvement of >=15 Letters From Baseline in the Study Eye. Started Feb 2005; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00168389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168389.